Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?

Stefani C, Miricescu D, Stanescu-Spinu II, Nica RI, Greabu M, Totan AR, Jinga M. · 2021

Read Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now? by Stefani C, Miricescu D, Stanescu-Spinu II, Nica RI, Greabu M, Totan AR, Jinga M. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8508474.txt.

Introduction

Stefani and co-authors take stock of growth factor signaling in colorectal cancer. This cancer ranks as the fourth most common cause of cancer death and illness worldwide. Its rates climb each year, in young adults as well as older groups. Many factors feed it, from diet and smoking to gut microbes and gene faults.

Growth factors keep tumor cells growing, moving, and invading. Three receptors stand out as overactive in this cancer. Their signals run through the PI3K/AKT/mTOR path and the MAPK family paths. The review maps where research now stands on these routes. It asks what the paths mean for future treatment.

Catalog record

CREATORStefani C, Miricescu D, Stanescu-Spinu II, Nica RI, Greabu M, Totan AR, Jinga M.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE109 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8508474

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now? By Constantin Stefani, Daniela Miricescu, Iulia-Ioana Stanescu-Spinu, Remus Iulian Nica, Maria Greabu, Alexandra Ripszky Totan, Mariana Jinga, Anica Dricu Published in: International Journal of Molecular Sciences DOI: 10.3390/ijms221910260 ABSTRACT Abstract Colorectal cancer (CRC) is a predominant malignancy worldwide, being the fourth most common cause of mortality and morbidity. The CRC incidence in adolescents, young adults, and adult populations is increasing every year. In the pathogenesis of CRC, various factors are involved including diet, sedentary life, smoking, excessive alcohol consumption, obesity, gut microbiota, diabetes, and genetic mutations. The CRC tumor microenvironment (TME) involves the complex cooperation between tumoral cells with stroma, immune, and endothelial cells. Cytokines and several growth factors (GFs) will sustain CRC cell proliferation, survival, motility, and invasion. Epidermal growth factor receptor (EGFR), Insulin-like growth factor -1 receptor (IGF-1R), and Vascular Endothelial Growth Factor -A (VEGF-A) are overexpressed in various human cancers including CRC. The phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) and all the three major subfamilies of the mitogen-activated protein kinase (MAPK) signaling pathways may be activated by GFs and will further play key roles in CRC development. The main aim of this review is to present the CRC incidence, risk factors, pathogenesis, and the impact of GFs during its development. Moreover, the article describes the relationship between EGF, IGF, VEGF, GFs inhibitors, PI3K/AKT/mTOR-MAPK signaling pathways, and CRC. Keywords: colorectal cancer, growth factors, PI3K/AKT/mTOR, MAPK, growth factor inhibitors 1. INTRODUCTION If, in 1950, colorectal cancer (CRC) was a rare malignancy, today, it became a predominant form worldwide [1]. After breast, lung, and prostate cancer, CRC is the fourth most common cause of cancer [2] and aggressive malignancy [3]. In the United States, it is the second-leading cause of death [2]. Every year, more than 1.2 million patients are diagnosed with CRC, and more than 600,000 lose the battle with this disease [4]. Worldwide, CRC is the third most common cancer, and the incidence is increasing with age [5,6,7]. In Europe, around 11% of CRC cases are attributed to overweight and obesity, especially visceral fat or abdominal obesity. The epidemiologic studies reported an incidence of 30–70% increased risk of CRC in obese men [8]. The most common CRC subsets are colon, proximal colon, distal colon, and rectum [9]. Since 1994, the CRC incidence in adolescents and young adults under 45 years has been increasing every year [10,11,12,13]. The statistical data published in 2014 revealed that 26% of proximal colon cancers were diagnosed in women younger than 50 years, while 56% of the cases were registered in women aged 80 years and older [14]. Compared with older CRC patients, early-onset CRC is a heterogenous group that is distinct from the clinical, pathologic, and molecular points of view [15]. Therefore, an increased incidence was observed between 49 and 50 years [16]. Kim SE reported that women are more prone to developing right-sided (proximal) colon cancer compared with men. Proximal colon cancer is a more aggressive form versus the left-sided (distal) form [17]. Depending on the mutation origin, CRC carcinomas are classified as sporadic (70%), inherited (5%), and familial (25%). Unfortunately, metastatic CRC (mCRC) is often incurable in most cases, representing 13% of all diagnosed cancers [18,19], with an overall survival rate of 13% [18,20]. Corroborating all the information received from genomic, epigenomic, transcriptomic, and microenvironment levels, CRC has molecular heterogeneity. Moreover, genomic events accumulated during carcinogenesis remain the leaders of cancer progression in the metastatic stage [21]. For early CRC, the 5-year survival rate is ~90%, but this rate decreases to 15% in the case of mCRC [22]. 2. RISK FACTORS IN CRC Both environmental and genetic factors are involved in the etiology of CRC [23]. More than 80% of CRC cases are sporadic, as patients do not present a family history [23]. Therefore, the majority of the CRC cases (>90%) can be prevented if they are tested and screened early [24]. Several modifiable risk factors are involved in CRC pathogenesis such as diet, obesity, sedentary life, smoking, and moderate-to-heavy alcohol consumption [25]. Diet plays a pivotal role in CRC development [26,27], the consumption of unhealthy food being a significant factor in CRC development [28]. Moreover, a diet rich in red meats, processed meats, saturated animal fats, spicy foods, refined carbohydrates are associated with increased CRC development [27]. The International Agency for Research on Cancer (WHO-IARC) classified the consumption of processed meat as “carcinogenic to humans”. Several compounds present in red (haem iron) and/or processed meat (nitrates and nitrites) as well as those formed during cooking will react with colorectal mucosa and promote carcinogenesis [29]. Experimental studies, performed on rodent models, reported that red meat haem iron induces lipid oxidation with the formation of 4-hydroxynonenal (HNE) from n-6 fatty acids. Aldehydes’ synthesis is correlated in rats with preneoplastic lesions. In vitro, it has been observed that haem iron and aldehydes can enhance cellular inflammatory processes and cellular permeability, as well as promoting cellular DNA damage [30]. The process of meat cooking can incorporate or develop mutagens and carcinogens, which have been shown to enhance carcinogenesis. During high-temperature or open-flame meat cooking, heterocyclic amines (HCAs) and polycyclic aromatic hydrocarbons (PAHs) are formed. In meat, the most common PAH compound is benzo(a)pyrene. Cytochrome P450 enzymes activate these pro-carcinogens, which will be further converted in several metabolic pathways [31]. Moreover, N-nitroso compounds (NOC) obtained by the interaction between nitrogen oxides or nitrite with secondary amines and N-alkillamides have CRC carcinogenic properties [32]. In addition, the consumption of red meat and other animal products is conducive to trimethylamine N-oxide (TMAO) synthesis, a gut microbiota-derived metabolite of choline and L-carnitine, associated with an increased risk of CRC, cardiovascular disease, and diabetes. The correlation between TMAO and cancer is performed via inflammation, OS, DNA damage, and protein folding disruption [33]. The results from the epidemiologic and experimental studies performed in the last few decades revealed that calcium, fibers, milk, and whole grains decrease the CRC incidence, while red and processed meat increase the risk [26]. While the Western society prefers to eat red and processed meat associated with an increased cancer incidence, the Mediterranean diet is correlated with a decreased cancer incidence [34]. Smoking and a sedentary lifestyle are major risk factors for early-onset CRC [35]. Smoking cigarettes generates more than 7000 toxic chemicals, with at least 70 known carcinogens that can affect the entire human body. Carcinogens from the cigarette smoke (nitrosamines, heterocyclic amines, benzene, and polycyclic aromatic hydrocarbons) directly interact with the colorectal mucosa in two ways—by direct ingestion or through the bloodstream. Overall, smoking has a direct oncogenic effect, being correlated with CRC adenoma [36]. Moreover, passive smoking is an independent risk factor for CRC neoplasia in non- and former smokers [37]. In addition, it seems that physical activity after CRC diagnosis may reduce the risk of mortality by 38% [38]. In 2015, Baena R and co-workers published the results of the epidemiologic studies from EMBASE and PubMed-NCBI, carried out since November 2014, and revealed that obesity increases the risk of CRC by 19%, while regular physical activity reduces this risk by 24%. In addition, fish, fibers, and milk consumption reduce the risk of colon

Read the complete text